Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Tuning the Antigen Density Requirement for CAR T-cell Activity
2020
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
In vivo generation of human CD 19‐ CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
2018
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
2020
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
2023 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Delivery strategies of cancer immunotherapy: recent advances and future perspectives
2019
Engineering precision nanoparticles for drug delivery
2020 Standout
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
2017
Cytokines in CAR T Cell–Associated Neurotoxicity
2020
A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity
2020
Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting
2019
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
2019 StandoutNobel
Engineered T Cell Therapy for Cancer in the Clinic
2019
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
2020
Clinical lessons learned from the first leg of the CAR T cell journey
2019
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
2020
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Cytokine release syndrome
2018
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Hepatocellular carcinoma
2021 Standout
Genetically engineered T cells for cancer immunotherapy
2019
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
2018
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
2018
Engineering interferons and interleukins for cancer immunotherapy
2022
Delivery technologies for cancer immunotherapy
2019 Standout
Recent updates on CAR T clinical trials for multiple myeloma
2019
Granulocyte–macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators
2019
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
2018
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
2018
Programming CAR-T cells to kill cancer
2018
Pyroptosis: mechanisms and diseases
2021 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The Pharmacology of T Cell Therapies
2018
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
CAR-T cell and Personalized Medicine
2019
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
2020
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
2019
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
De novo design of tyrosine and serine kinase-driven protein switches
2021 StandoutNobel
Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains
2017
Mechanisms of resistance to CAR T cell therapy
2019
Therapeutic T cell engineering
2017 Nature
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
2022
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Myeloid cell and cytokine interactions with chimeric antigen receptor-T-cell therapy: implication for future therapies
2019
Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
2018
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
2018
Supercharging adoptive T cell therapy to overcome solid tumor–induced immunosuppression
2019
Glycan-directed CAR-T cells
2018
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
2018
Current Progress in CAR-T Cell Therapy for Hematological Malignancies
2020
Cytokine Storm
2020 Standout
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
Tumor Antigen Escape from CAR T-cell Therapy
2018
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function
2021
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
De novo design of protein logic gates
2020 StandoutScienceNobel
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
2019
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
2018
Works of Daniel Li being referenced
Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
2017
Cytokine release syndrome (CRS) and neurotoxicity (NT) after CD19-specific chimeric antigen receptor- (CAR-) modified T cells.
2017
Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapy
2019
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy
2017
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
2016
Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy
2017